Introduction {#s1}
============

All viruses depend on host cell functions for multiple replication steps, and modulate host pathways to make infected cells a better environment for virus replication. Accordingly, both targeted and genome-wide studies identifying cellular factors and virus-host interactions that support or inhibit virus replication offer great value for understanding infection and developing novel antiviral approaches[@pone.0095799-Hao1]--[@pone.0095799-Stertz1].

The largest genetic class of viruses are the positive-strand RNA viruses, which encapsidate messenger-sense single-stranded RNA and include many important human pathogens like hepatitis C virus, West Nile virus, many animal pathogens, and the majority of known plant viruses. One model that has been used to analyze the mechanisms of positive-strand RNA virus replication and virus-host interaction is Flock House virus (FHV), the best-studied member of the *Nodaviridae* family of animal viruses. FHV has a small, bipartite RNA genome. The smaller genomic RNA, RNA2 (1.4 kb), encodes the capsid protein precursor. The larger genomic RNA, RNA1 (3.1 kb), encodes multifunctional protein A, which has RNA-dependent RNA polymerase, self-interaction and membrane-interaction domains and is the sole viral protein required for FHV RNA replication [@pone.0095799-Price1]--[@pone.0095799-Ball1]. In vivo, RNA1 can replicate independently of RNA2, by translating protein A, which then produces and copies a negative-strand RNA1 replication intermediate ([Figure 1A](#pone-0095799-g001){ref-type="fig"}). Protein A-directed replication of RNA1 also produces a small sub-genomic mRNA, RNA3, containing two overlapping open reading frames (ORFs) encoding proteins B1 and B2. While B1, which corresponds to the C-terminus of protein A, is not required for FHV replication [@pone.0095799-Dasgupta1], B2 is an RNAi inhibitor required for efficient FHV replication in insect or nematode cells [@pone.0095799-Schwartz1], [@pone.0095799-Lu1]. As with all positive-strand RNA viruses, FHV RNA replication occurs on intracellular membranes. Specifically, in *Drosophila* cells, a natural host for productive FHV infection, FHV RNA replication and transcription occur in virus-induced, ∼50 nm invaginations of outer mitochondrial membranes [@pone.0095799-Kopek1].

![Structure, plasmid-directed synthesis and replication of wt FHV RNA1 and *Renilla* luciferase-expressing derivative F1R.\
A) Diagram of FHV RNA1 expression plasmid pF1, which uses the galactose-inducible, glucose-repressible *GAL*1 promoter to express a wt FHV RNA1 transcript whose 3′ end is formed by self-cleavage by a hepatitis delta virus ribozyme [@pone.0095799-Sharmeen1]. RNA1 is translated to produce protein A, the multifunctional FHV RNA synthesis protein, which directs RNA1 replication and, through a truncated negative-strand intermediate ((-) sgRNA3), production and subsequent replication of RNA3 (sgRNA3), a subgenomic mRNA that encodes two ORFs: B1, the C-terminus of protein A, and B2, an RNA silencing suppressor. B). Plasmid pFA is a pF1 derivative that retains the complete FHV protein A ORF but has the FHV 5′ and 3′ untranslated regions, which contain essential cis-acting RNA replication signals, replaced with nonviral sequences. The resulting transcript from the pFA *GAL1* promoter translates full length, wt FHV protein A, but cannot serve as an RNA replication template. Plasmid pF1R is a second pF1 derivative that retains the full length RNA1 sequence, but bears an early frameshift mutation in the protein A ORF and an insertion of the *Renilla* luciferase ORF immediately after the initiation codon of the B1 ORF AUG in RNA3. The resulting pF1R transcript thus cannot translate protein A but, when protein A is provided *in trans* from pFA, is replicated and produces a *Renilla* luciferase-expressing subgenomic RNA3 derivative.](pone.0095799.g001){#pone-0095799-g001}

To identify host genes that facilitate or inhibit FHV replication, we utilized FHV's ability to replicate in an unusually wide range of cells. Although originally isolated from insects, FHV RNA also efficiently replicates and directs the production of infectious virions in mammalian cells, plant cells, and the yeast *Saccharomyces cerevisiae,* a widely used model for genetics, cellular and molecular biology [@pone.0095799-Price1]. Many powerful genetic resources exist for *S. cerevisiae*, including an ordered, genome-wide, single gene deletion or yeast knockout (YKO) library that allows systematically studying the effects of each gene on a selected process, such as FHV replication. This YKO library was previously used to identify genes that facilitate or inhibit brome mosaic virus (BMV) and tombusvirus RNA replication [@pone.0095799-Kushner1], [@pone.0095799-Panavas1]. While they are all positive-strand RNA viruses, BMV and tombusviruses differ from FHV in many aspects of their cellular and molecular biology and naturally infect plant hosts rather than animal hosts as for FHV and *Nodaviridae*. Moreover, very limited overlap was found among the host genes that strongly modulated BMV and tombusvirus replication. Thus, analysis of host factors required for FHV replication should shed further light on the replication pathways and host interactions of positive-strand RNA viruses.

Here we present a systematic functional genomics analysis of host genes that affect FHV replication using ∼4,500 yeast deletion mutant strains, each with a single known ORF knocked out, covering 80% of the yeast genome. Initial high throughput screening was conducted with an RNA1 derivative containing a *Renilla* luciferase reporter gene, whose expression depends on viral RNA replication and sub-genomic mRNA synthesis. Implicated candidate genes were then validated by further testing of their effects on the replication of wt FHV RNA1, confirming 65 genes whose deletion produced significant effects on FHV genomic RNA1 replication and sub-genomic RNA3 production.

Results and Discussion {#s2}
======================

Generating an FHV RNA1 Derivative for High-throughput Screening {#s2a}
---------------------------------------------------------------

To facilitate informative, high throughput assays of FHV RNA-dependent RNA replication in the ordered YKO strain library, we generated plasmid pF1R, which uses the galactose-inducible *GAL1* promoter to express an FHV genomic RNA1 derivative with two engineered changes ([Figure 1B](#pone-0095799-g001){ref-type="fig"}). The first change addressed the complication that wt FHV RNA1 is both the mRNA that expresses RNA replication protein A and an RNA replication template that is multiplied by protein A ([Figure 1A](#pone-0095799-g001){ref-type="fig"}). Consequently, any host gene deletion in the YKO library that interfered with FHV RNA replication would have its effects further amplified by the resulting secondary inhibition of protein A expression. To avoid such unwanted amplification of YKO mutant effects, we separated RNA1's mRNA function from its replication template activity by inserting a frameshift mutation early in the protein A ORF, and provided protein A in trans by transcription of a non-replicating protein A mRNA from a second DNA expression plasmid, pFA ([Figure 1B](#pone-0095799-g001){ref-type="fig"} and references [@pone.0095799-Price1], [@pone.0095799-Lindenbach1]).

Second, to facilitate high throughput assays of FHV RNA replication in the ordered YKO strain library, the *Renilla* luciferase gene was inserted immediately after the AUG of B1 ORF in sub-genomic RNA3, such that *Renilla* luciferase activity was expressed in a fashion that depended on and served as a measure of FHV RNA-dependent RNA replication and subgenomic RNA3 synthesis [@pone.0095799-Price1] ([Figure 1B](#pone-0095799-g001){ref-type="fig"}).

The data in [figure 2](#pone-0095799-g002){ref-type="fig"} confirmed that, as intended, *Renilla* luciferase activity was only detected when both pFA and pF1R were provided (condition 3), as required for RNA1 replication and subgenomic RNA3 production [@pone.0095799-Price1], [@pone.0095799-Lindenbach1]. Only low level background signals were detected if either pFA or pF1R were omitted (conditions 1--2), or if wt pFA was replaced with its nonfunctional derivative pFA(D692E) (condition 4), a protein A mutant with an inactivating single D~692~ to E amino acid change in a conserved polymerase motif [@pone.0095799-VanWynsberghe1].

![Validation of FHV replication-dependent luciferase expression.\
Yeasts transformed with the indicated plasmids were assayed for luciferase activity. As shown, significant luciferase activity was only observed when there is active FHV RNA replication and subgenomic mRNA synthesis, which depend on expressing both functional protein A (expressed from pFA) and a functional FHV RNA1 derived template RNA (from pF1R). Neither protein A (pFA) alone, nor the RNA1 derived template RNA (pF1R) alone produced luciferase activity above background. The need for FHV RNA synthesis is further demonstrated by the effects of a polymerase-inactivating mutation in the protein A active site (expressed from pFA(GED)), which reduces luciferase activity to background level even when expressed together with pF1R.](pone.0095799.g002){#pone-0095799-g002}

Testing 4,491 Yeast Knock-Out (YKO) Strains for Effects on FHV Replication {#s2b}
--------------------------------------------------------------------------

Except for 301 yeast deletion strains with previously annotated significant growth defects, the remaining 4,491 strains of the BY4743 homozygous diploid yeast knock-out (YKO) non-essential library were tested for their ability to support FHV RNA replication as follows: yeasts were transformed with plasmid pFA and pF1R, and the resulting yeast transformants were grown in liquid synthetic defined (SD) medium with histidine and leucine omitted to maintain plasmid selection. Glucose was provided as the carbon source for the first passage in liquid medium. After one day of growth, the yeasts were sub-cultured to a starting density of OD~600~ = 0.075 in SD medium with galactose for two more passes to induce virus replication. Yeast growth was monitored by measuring culture OD~600~. For each strain, *Renilla* luciferase activity was measured using a whole cell assay as described [@pone.0095799-Kushner1], as a measure of FHV-directed RNA replication and expression.

Two independent passes of the above screen were performed across the 4,491 YKO strains, which were arrayed in 48 96-well plates. The YKO library contains 84 duplicate strains, which leaves 4,407 unique yeast deletion mutant strains. In the first and second pass, 204 and 212 unique strains respectively could not be assayed as they either failed to be transformed with pFA + pF1R or to grow in galactose liquid medium. Of the affected strains, 147 were not assayed in either pass, and 122 were only assayed once. The remaining 4,138 unique strains were tested twice for FHV replication, with a small portion tested four times because they were duplicated in the library. The Pearson's correlation coefficient between the two passes is 0.446.

To stabilize the variance between samples with high and low luciferase activity readings, a power transformation ( root) was applied to the luciferase readings [@pone.0095799-Huang1], [@pone.0095799-Sanford1]. Based on the common assumption that most cell genes should not strongly affect virus replication, as was confirmed by the screen results, each reading then was normalized to the median of the relevant 96-well plate. The complete data from both primary screen passes is shown in [table S1](#pone.0095799.s001){ref-type="supplementary-material"}.

Validation Testing Confirms 65 Genes with Strong Effects on FHV Replication {#s2c}
---------------------------------------------------------------------------

The data from the two screening passes of the YKO library were filtered by several criteria to select strains for further analysis. First, experience shows that, irrespective of the host pathways affected, most mutant yeast strains with extreme high or low growth rates show strong, apparently non-specific effects on virus-directed reporter gene expression [@pone.0095799-Kushner1]. In general, FHV-expressed luciferase activity accumulates to lower levels per cell in fast-growing strains, and to higher levels per cell in slow-growing strains. These results appear consistent with effects dominated by changes in the balance between varying host cell division rates and a relatively fixed rate of FHV RNA replication. Thus, strains with extreme changes in growth rate appear less likely to be informative about specific mechanisms of virus replication and virus-host interaction. Accordingly, to avoid mis-calling non-specific effects of cell growth rate as specific effects on virus replication, in each pass the final OD~600~ of each yeast strain before *Renilla* luciferase assay was normalized to the median of its respective 96-well plate as a measure of growth rate, and the strains with the highest 5% and lowest 5% of growth rates from each primary screen pass (see [Table S1](#pone.0095799.s001){ref-type="supplementary-material"}) were excluded from the next phases of analysis pursued here.

For initial validation testing, we first selected the 79 strains ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}) that in both primary screen passes showed \>5-fold changes in luciferase expression relative to wild type yeast ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}). Next, to provide a more inclusive assay, 180 additional strains ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}) that showed at least a two-fold change in FHV-directed luciferase expression in both primary screen passes were re-screened six times using the *Renilla* luciferase assay. T-tests of the resulting data confirmed that, at a false discovery rate (FDR) of ≤5%, 46 strains (25%) showed significant differences from wild type yeast ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}).

Next, the resulting 79+46 = 125 strains were analyzed for effects on FHV RNA replication using a more direct assay. These strains were transformed with plasmid pF1 ([Figure 1B](#pone-0095799-g001){ref-type="fig"}), which expresses wt FHV RNA1 that both expresses protein A and directs its own RNA replication in *cis*. FHV genomic RNA1 and subgenomic RNA3 levels were measured by Northern blotting and normalized to the 18S rRNA level in each sample ([Figure 3](#pone-0095799-g003){ref-type="fig"}). Four independent repeats of such Northern blot data for all 125 candidate strains from the primary screens then were analyzed by paired t-tests for changes in both RNA1 and RNA3 accumulation relative to wt yeast. For the 79 mutant strains with \>5 fold changes in FHV-directed luciferase expression in the primary screens, these Northern blot assays validated 43 strains (55%) as distinct from wt yeast at a false discovery rate of≤5% ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}). Similarly, for the 46 strains with 2- to 5-fold changes in luciferase expression, 22 strains (48%) were validated ([Table S1](#pone.0095799.s001){ref-type="supplementary-material"}). These validation rates are similar to those found, e.g., in prior screens for host factors that modulate *Drosophila* C virus replication [@pone.0095799-Cherry2].

![FHV RNA1 replication in selected yeast deletion mutants.\
Yeast strains with the indicated gene deletions were transformed with plasmid pF1 ([Figure 1A](#pone-0095799-g001){ref-type="fig"}) and, following galactose-induction of pF1 transcription, FHV genomic RNA1 replication and subgenomic RNA3 production were assayed by Northern blot hybridization. The histograms show the averages and standard deviations of RNA1 and RNA3 levels across four independent experiments. Representative Northern blots are shown above each histogram. A). FHV wild type RNA1 replication in all 8 deletion mutants whose deleted gene functions facilitate FHV replication. WT denotes the no deletion control. B). FHV wild type RNA1 replication in a selected subsets of yeast deletion mutants whose deleted gene functions normally inhibit FHV replication. Accordingly, these strains show increased FHV replication.](pone.0095799.g003){#pone-0095799-g003}

The 43+22 = 65 confirmed genes, their annotated functions, and average RNA1 and RNA3 accumulation levels are shown in [tables 1](#pone-0095799-t001){ref-type="table"} and [2](#pone-0095799-t002){ref-type="table"}. [Figure 3](#pone-0095799-g003){ref-type="fig"} shows sample Northern blots with histograms of RNA1 and RNA 3 levels relative to those of wild type yeast.

10.1371/journal.pone.0095799.t001

###### Yeast genes that support FHV replication.

![](pone.0095799.t001){#pone-0095799-t001-1}

  Mitochondrial                                                                                                                                             
  ------------------- ---------- ------------------------------------------------------------- ---------------- -------- -------- ---------------- -------- --------
  **ORF**              **Gene**                     **Molecular Function**                      **RNA1 (%WT)**   **t1**   **q1**   **RNA3 (%WT)**   **t3**   **q3**
  **Translation**                                                                                                                                           
  YPL183W-A                                   structural constituent of ribosome                     67%          −5.1     1.7%         65%          −3.5     4.5%
  Metabolism                                                                                                                                                
  YOL071W                SDH5                       oxidoreductase activity                          59%          −6.0     1.5%         34%          −3.5     4.4%
  YKL148C                SDH1                       oxidoreductase activity                          32%         −13.8     0.6%          6%         −41.0     0.2%
  YPL037C                EGD1                      unfolded protein binding                          42%         −41.5     0.3%         32%         −44.6     0.2%
  **Cytoplasmic**                                                                                                                                           
  **Chaperone**                                                                                                                                             
  YLR410W                VIP1                      inositol phosphate kinase                         27%         −23.3     0.3%         10%         −34.0     0.2%
  **Kinase**                                                                                                                                                
  YOL045W                PSK2              protein serine/threonine kinase activity                  37%         −12.7     0.6%         14%         −10.5     2.0%
  YKL116C                PRR1     receptor signaling protein serine/threonine kinase activity        23%         −29.3     0.3%          5%         −14.8     1.1%
  **Transcription**                                                                                                                                         
  YOR083W                WHI5             specific transcriptional repressor activity                32%         −20.7     0.3%         22%          5.8      2.7%

10.1371/journal.pone.0095799.t002

###### Yeast genes that suppress FHV replication.

![](pone.0095799.t002){#pone-0095799-t002-2}

  Nucleus                                                                                                                                                                                             
  ------------------------------------------------------------- ---------- ------------------------------------------------------------- ---------------- -------- -------- ---------------- -------- --------
  **Transcription**                                                                                                                                                                                   
  YDR295C                                                          HDA2                    histone deacetylase activity                        572%         5.6      1.5%         735%         4.58     3.2%
  YNL059C                                                          ARP5                    structural molecule activity                        564%         8.8      0.8%         924%         7.47     2.2%
  YJL115W                                                          ASF1                           histone binding                              413%         21.3     0.3%         604%        22.00     0.6%
  YER040W                                                          GLN3                          metal ion binding                             389%         10.0     0.7%         330%         3.21     4.7%
  YLR226W                                                          BUR2         cyclin-dependent protein kinase regulator activity             358%         5.8      1.5%         347%         6.20     2.6%
  YML036W                                                         CGI121                    molecular_function unknown                         226%         5.7      1.5%         277%         3.62     4.3%
  YEL009C                                                          GCN4                             DNA binding                                201%         5.7      1.5%         259%        10.02     2.0%
  YDL115C                                                          IWR1                     molecular_function unknown                         511%         5.2      1.6%         695%         3.97     4.0%
  **Chromatin remodeling**                                                                                                                                                                            
  YEL044W                                                          IES6                     molecular_function unknown                         372%         7.3      1.0%         759%         5.12     2.9%
  YJL127C                                                         SPT10                    sequence-specific DNA binding                       362%         7.2      1.0%         446%         3.92     4.0%
  **DNA repair**                                                                                                                                                                                      
  YDR369C                                                          XRS2                             DNA binding                                283%         4.0      2.5%         326%         3.40     4.6%
  **Cell Cycle**                                                                                                                                                                                      
  YAL024C                                                          LTE1             guanyl-nucleotide exchange factor activity                 453%         11.4     0.6%         873%         7.78     2.2%
  YHR191C                                                          CTF8                     molecular_function unknown                         416%         7.7      0.9%         477%         4.83     3.1%
  YPL008W                                                          CHL1                         nucleotide binding                             289%         20.0     0.3%         448%         5.58     2.8%
  ^\#^YPR046W                                                     MCM16                           protein binding                              276%         7.0      1.1%         389%         3.13     4.8%
  YMR014W                                                         BUD22                     molecular_function unknown                         566%         8.8      0.8%         901%         6.20     2.6%
  **Cytoplasmic**                                                                                                                                                                                     
  **ORF**                                                        **Gene**                     **Molecular Function**                      **RNA1 (%WT)**   **t1**   **q1**   **RNA3 (%WT)**   **t3**   **q3**
  **Translation, protein biosynthesis & ribosome biogenesis**                                                                                                                                         
  YDR025W                                                         RPS11A                structural constituent of ribosome                     677%         5.2      1.6%         637%         3.85     4.0%
  YLR441C                                                         RPS1A                 structural constituent of ribosome                     593%         5.8      1.5%        1043%         3.74     4.1%
  YKL006W                                                         RPL14A                structural constituent of ribosome                     585%         17.5     0.4%         691%         7.90     2.2%
  YGR027C                                                         RPS25A                structural constituent of ribosome                     484%         6.9      1.1%         584%         5.09     2.9%
  [\*](#nt102){ref-type="table-fn"}YGL076C                        RPL7A                 structural constituent of ribosome                     431%         9.0      0.8%         628%         5.96     2.7%
  YNL069C                                                         RPL16B                structural constituent of ribosome                     342%         21.7     0.3%         661%        10.11     2.0%
  YMR142C                                                         RPL13B                structural constituent of ribosome                     310%         7.6      0.9%         414%         4.24     3.6%
  YMR143W                                                         RPS16A                structural constituent of ribosome                     299%         7.7      0.9%         306%         5.19     2.9%
  YMR230W                                                         RPS10B                structural constituent of ribosome                     239%         4.2      2.3%         293%         4.35     3.6%
  YPR132W                                                         RPS23B                structural constituent of ribosome                     229%         6.6      1.2%         332%         9.30     2.2%
  YDL083C                                                         RPS16B                structural constituent of ribosome                     212%         13.5     0.6%         333%         3.92     4.0%
  YBL072C                                                         RPS8A                 structural constituent of ribosome                     209%         7.6      0.9%         322%         7.43     2.2%
  **RNA processing and stablity**                                                                                                                                                                     
  YOL041C                                                         NOP12                             RNA binding                                244%         7.0      1.1%         364%         3.11     4.9%
  YGR159C                                                          NSR1                         nucleotide binding                             571%         11.1     0.6%         644%         5.05     2.9%
  YKL009W                                                          MRT4                mRNA turn over and ribosome assmebly                    558%         3.2      3.8%         853%         3.05     5.0%
  ^\#^YOR076C                                                      SKI7                     3′-5′ exonuclease activity                         309%         17.2     0.4%         343%         5.47     2.8%
  ^\#^YLR398C                                                      SKI2                        RNA helicase activity                           335%         7.6      0.9%         339%         5.84     2.7%
  ^\#^YPR189W                                                      SKI3                   translation repressor activity                       254%         8.7      0.8%         324%         5.53     2.8%
  YHR081W                                                          LRP1                   nuclear exosome (RNase complex)                      336%         11.9     0.6%         433%         7.28     2.2%
  YPL213W                                                          LEA1     RNA splicing factor activity, transesterification mechanism        887%         3.9      2.6%        1119%         3.47     4.5%
  ^\#^YCR063W                                                     BUD31                            RNA splicing                                194%         3.0      4.5%         152%         3.32     4.7%
  YPL157W                                                          TGS1                        transferase activity                            584%         19.2     0.3%         981%         4.42     3.5%
  **Transport**                                                                                                                                                                                       
  ^\#^YLR373C                                                     VID22                          vacuola transport                             381%         9.5      0.7%         569%         4.89     3.0%
  YPR139C                                                         VPS66                       vacuola protein sorting                          380%         6.5      1.2%         741%         4.32     3.6%
  [\*](#nt102){ref-type="table-fn"} ^\#^YKL041W                   VPS24                           protein binding                              369%         5.1      1.7%         585%         3.77     4.1%
  YLR360W                                                         VPS38                 late endosome to vacuola transport                     340%         10.4     0.7%         461%         7.53     2.2%
  YGL023C                                                          PIB2                          metal ion binding                             312%         5.4      1.6%         283%         4.17     3.6%
  YDR320C                                                          SWA2                           protein binding                              505%         8.3      0.9%         651%         6.47     2.6%
  YPL195W                                                          APL5                           protein binding                              220%         8.2      0.9%         246%        17.99     0.7%
  YDR276C                                                          PMP3                          cation transport                              166%         7.3      1.0%         204%        11.25     2.0%
  ^\#^YPL226W                                                      NEW1                     nucleotide binding, ATPase                         200%         7.9      0.9%         214%         3.37     4.6%
  **Chaperone**                                                                                                                                                                                       
  YJR032W                                                          CPR7                         chaperone activity                             320%         6.4      1.3%         438%         3.23     4.7%
  **Metabolism**                                                                                                                                                                                      
  YDR226W                                                          ADK1                         nucleotide binding                             430%         6.1      1.4%         663%         5.86     2.7%
  YML022W                                                          APT1                        transferase activity                            208%         3.5      3.3%         267%         5.09     2.9%
  YPL017C                                                         IRC15                       oxidoreductase activity                          238%         11.3     0.6%         386%         7.90     2.2%
  YHR204W                                                          MNL1                         hydrolase activity                             299%         5.0      1.7%         313%         5.08     2.9%
  **Protein modification & signal transduction**                                                                                                                                                      
  YOR080W                                                          DIA2                    SCF ubiquitin ligase complex                        277%         4.4      2.2%         575%         4.22     3.6%
  YMR116C                                                          ASC1                     signal transducer activity                         593%         10.8     0.6%         760%         5.17     2.9%
  **Unknown**                                                                                                                                                                                         
  YOR235W                                                         IRC13                                                                        427%         10.2     0.7%         613%        6.563     2.6%
  YLR232W                                                                                                                                      302%         9.2      0.7%         314%        7.875     2.2%
  ^\#^YDR241W                                                     BUD26                         bud site selection                             515%         12.6     0.6%         981%        8.393     2.2%

\#Genes also identified to affect BMV replication.

\*Genes also identified to affect TBSV replication.

Diverse Functions of Genes Validated to Affect FHV Replication {#s2d}
--------------------------------------------------------------

Among the 65 confirmed genes, only eight showed decreased FHV replication when deleted, indicating that their functions support FHV replication ([Table 1](#pone-0095799-t001){ref-type="table"} and [Figure 3A](#pone-0095799-g003){ref-type="fig"}). Three of these genes encode proteins that localize to mitochondria, the sites of FHV RNA replication [@pone.0095799-Kopek1], [@pone.0095799-Miller1]. These include one mitochondrial ribosomal protein, *YPL183W-A*, and two subunits of the succinate dehydrogenase complex, *SDH1* and *SDH5* (also named *EMI5*). The remaining 5 genes encode cytoplasmic proteins, including the *PRR1* and *PSK2* kinases involved in signal transduction [@pone.0095799-Rutter1], [@pone.0095799-Burchett1]; inositol phosphate kinase *VIP1* that functions in actin cytoskeleton organization [@pone.0095799-Mulugu1]; *EGD1*, a ribosome-associated chaperone involved in folding and targeting of newly synthesized peptides, including some destined for mitochondria [@pone.0095799-George1]; and *WHI5,* a cell cycle-regulated transcriptional repressor that accelerates G1/S transition [@pone.0095799-Costanzo1].

Fifty-seven confirmed genes showed increased levels of FHV replication when deleted, indicating that these genes normally repress FHV replication ([Table 2](#pone-0095799-t002){ref-type="table"} and [Figure 3B](#pone-0095799-g003){ref-type="fig"}). For some deletion strains in this class, the mean levels of viral RNA1 and RNA3 replication were associated with relatively large standard deviations, but nevertheless passed statistical confirmation due to variably but consistently increased RNA accumulation. For example, in yeast with a deletion of *LEA1*, FHV RNA1 accumulation in individual experiments was always increased above wt yeast, but ranged from 2.6- to 23-fold higher than in wt yeast ([Figure 3B](#pone-0095799-g003){ref-type="fig"}).

Among the 57 confirmed genes whose deletion increased FHV RNA replication, 41 encoded proteins that localized to the cytoplasm, while 16 encoded proteins that normally localized to the nucleus ([Table 2](#pone-0095799-t002){ref-type="table"}). Of the 41 cytoplasmic proteins, the largest functional group comprised 12 genes encoding ribosomal proteins, which is the only functional group of genes that was over-represented (p value = 8.3E-06) by GeneOntology pathway analysis ([Table 2](#pone-0095799-t002){ref-type="table"}). 10 of those genes are involved in RNA processing and stability. Their functions in RNA degradation may explain their roles in suppressing FHV RNA accumulation. Nine genes function in protein trafficking and vesicle mediated transport between sub-cellular organelles, which may suppress FHV replication by modulating trafficking of required viral proteins, cellular proteins or membrane lipids. The remaining implicated genes encode a stress response chaperone *(CPR7)* and proteins involved in nucleoside metabolism (*ADK1, APT1*), other metabolic processes (*IRC15, MNL1*), protein ubiquitination (*DIA2*), signal transduction (*ASC1*), and unknown functions (*YOR235W, YLR232W*, *YDR241W*).

The 16 genes with products normally localized to the nucleus include eight genes that function in transcription, two in chromatin remodeling, one in DNA repair and five in the cell cycle ([Table 2](#pone-0095799-t002){ref-type="table"}). Since FHV RNA replication is not known to require any nuclear stage, these genes might function indirectly in FHV replication in yeast, as in affecting expression of more directly acting host factor(s). Also, since DNA expression plasmids were used to initiate *trans* (pFA + pF1R) and *cis* (pF1) FHV RNA replication systems for primary genome-wide screening and validation testing, these genes might also affect plasmid-directed transcription or nucleo-cytoplasmic export of viral RNA.

Distinct Interactions of FHV and Other Viruses with Yeast YKO Strain Library {#s2e}
----------------------------------------------------------------------------

The yeast YKO system has previously been used to study host factor interactions of two other viruses, brome mosaic virus (BMV) [@pone.0095799-Kushner1] and tomato bushy stunt virus (TBSV) [@pone.0095799-Panavas1]. The FHV, BMV and TBSV studies were similar in that all three targets are positive strand RNA viruses, all three studies used the same YKO library, and the BMV and FHV screens both applied whole cell assays of *Renilla* luciferase expressed through viral RNA replication and sub-genomic mRNA synthesis. Interestingly, however, few host genes were identified in common between these studies. Only one gene, e.g., was identified to affect all three viruses: *VPS24,* a subunit of endosomal sorting complex required for transport III (ESCRT-III), whose deletion decreased TBSV and BMV replication, but increased FHV replication. The only additional common genes revealed by pairwise comparisons were ribosomal protein gene *RPL7A* ([Table 2](#pone-0095799-t002){ref-type="table"} ORF labeled with \*), whose deletion increased both FHV and TBSV replication, and nine genes (14% of host genes validated to affect FHV) that affected both BMV and FHV.

Among five host genes with similar effects on BMV and FHV replication, three are related RNA degradation genes *Ski2*, *Ski3/5*, and *Ski7,* which repress the levels of endogenous dsRNA replicons in yeast [@pone.0095799-Wickner1]. Similarly, deleting any of these genes increased accumulation of both FHV and BMV RNA replication products in yeast by 2--3 fold ([Figure 4A](#pone-0095799-g004){ref-type="fig"} and reference [@pone.0095799-Kushner1]). Both FHV and BMV replication also were suppressed by *BUD31*, an RNA splicing factor [@pone.0095799-Saha1] and *VID22*, implicated in membrane import and DNA repair [@pone.0095799-Bonetti1].

![Genes in the *Ski* pathway normally suppress FHV replication in yeast.\
Yeast strains with the indicated *Ski* gene deletions were transformed with plasmid pF1 ([Figure 1A](#pone-0095799-g001){ref-type="fig"}) and, following galactose-induction of pF1 transcription, FHV genomic RNA1 replication and subgenomic RNA3 production were assayed by Northern blot hybridization. The histograms show the averages and standard deviations of RNA1 and RNA3 levels across four independent experiments. Representative Northern blots are shown above the histograms.](pone.0095799.g004){#pone-0095799-g004}

Three genes that facilitate BMV replication were found here to suppress FHV replication ([Table 2](#pone-0095799-t002){ref-type="table"} ORFs labeled with \#). These include *NEW1*, involved in mRNA export and ribosome biogenesis [@pone.0095799-Li1]; *MCM16*, which functions in chromosome segregation [@pone.0095799-Sanyal1]; and *BUD26*, a gene of unknown function. In addition to these whole genome screening results, our recent targeted studies [@pone.0095799-GimenezBarcons1] revealed that RNA processing genes *Lsm1*, *Lsm6*, *Lsm7,* and *Dhh1* are required to efficiently recruit BMV genomic RNAs into both translation and RNA replication [@pone.0095799-Noueiry1], but restrict FHV RNA accumulation [@pone.0095799-GimenezBarcons1], possibly through their roles in deadenylation-dependent mRNA-decapping and decay. Additionally, 14 genes implicated in BMV replication [@pone.0095799-Kushner1] were excluded from the present FHV study due to growth defects on solid or liquid media after their knockout strains were transformed with pFA and pF1R (see table S1).Similarly, one gene implicated in TBSV replication [@pone.0095799-Panavas1] was excluded for the same reason.

The low overlap among host genes implicated in modulating FHV, BMV and TBSV replication is not surprising because many aspects of the biology of these viruses are distinct. For example, FHV naturally infects insects and replicates its RNA on the outer membranes of host cell mitochondria [@pone.0095799-Kopek1], while BMV and TBSV infect different plants and form RNA replication complexes on endoplasmic reticulum (ER) and peroxisome membranes, respectively [@pone.0095799-Schwartz1], [@pone.0095799-McCartney1]. Moreover, while FHV encodes only the single replication protein, protein A ([Figure 1](#pone-0095799-g001){ref-type="fig"}), BMV and TBSV each encode two replication proteins, an RNA-dependent RNA polymerase and an essential auxiliary protein that directs membrane targeting and modification [@pone.0095799-White1], and for BMV this auxiliary protein contains an RNA helicase-like domain that FHV and TBSV lack [@pone.0095799-Ahlquist1].

In addition to low overlap at the gene specific level, the FHV, BMV and TBSV YKO screens differed in the balance of virus-supporting and --interfering host genes identified. For FHV, 57 of 65 confirmed host genes (88%) increase virus replication when deleted, in contrast to TBSV, for which 90 of 96 confirmed genes (94%) decreased virus replication when deleted [@pone.0095799-Panavas1]. In contrast to these extremes, the BMV screen returned a more even result, with 39 of 97 confirmed host genes (40%) increasing and 58 genes (60%) decreasing BMV replication when deleted. The low yield of host genes that facilitate FHV replication may be related to the gene knockout screening approach used and FHV's ability to perform its intracellular replication steps in an unusually broad range of host cells, including insect [@pone.0095799-Lu1], [@pone.0095799-Miller1], mammalian[@pone.0095799-Johnson1], plant [@pone.0095799-Selling1], [@pone.0095799-Dasgupta2] and yeast [@pone.0095799-Price1], [@pone.0095799-Lindenbach1] cells. Given this broad host competence, whatever host genes are required for FHV replication must be conserved across kingdoms, and therefore are more likely to be essential for cell growth and thus excluded from the YKO non-essential gene library studied here.

In keeping with the distinct groups of host genes required by these three positive-strand RNA viruses, individual retroviruses like HIV-1 and Moloney murine leukemia virus (MuLV) also each require or are restricted by many different host factors [@pone.0095799-Konig1], [@pone.0095799-Takeuchi1]. Overall, recent genome-wide studies have revealed that viruses depend on an amazing variety of host genes for most if not all of their functions [@pone.0095799-Krishnan1]--[@pone.0095799-Bushman1]. The continuing elucidation of such virus-host interactions promises to radically transform understanding and control of viruses.

Materials and Methods {#s3}
=====================

Plasmid Construction {#s3a}
--------------------

pFA was generated by cloning the *HindIII/SpeI* fragment of pBDL7[@pone.0095799-Lindenbach1] into pRS425 [@pone.0095799-Christianson1]. pF1R was generated by replacing the GFP ORF in pF1~fs~-GFP~N2~ [@pone.0095799-Price1] with the *Renilla* luciferase ORF downstream of FHV B1 AUG codon.

Yeast Transformation, Culturing, and *Renilla* Luciferase Assays {#s3b}
----------------------------------------------------------------

Yeast strain BY4743 (WT) and the homozygous diploid deletion series (BY4743 strain background) were obtained from Research Genetics (Huntsville, AL). Standard yeast techniques were used. 96-well transformation and the *Renilla* luciferase assay were performed as previously described [@pone.0095799-Kushner1]. In brief, each yeast deletion mutant was inoculated in 0.5 ml YPAD plus glucose medium in a separate well of a 96-well high capacity plate, and grown at 30°C overnight. To increase transformation efficiency, the overnight culture was sub-cultured in YPAD plus glucose at ratio of 1∶10 and grown four hours at 30°C. The yeast cells then were pelleted and resuspended in 100 µl PEG/LiAc transformation solution containing 1 µg of each plasmid. The plate was incubated at 30°C for one hour, heat-shocked at 42°C for 15 minutes, and 5 µl of each transformation mixture was plated on synthetic defined (SD) medium with appropriate amino acids omitted to select for all desired plasmids. After three days incubation at 30°C, yeast transformants were ready for further analysis.

To assay for FHV directed replication and expression of the *Renilla* luciferase reporter gene as in [Fig. 1B](#pone-0095799-g001){ref-type="fig"}, yeast strains were transformed with pFA and pF1R plasmids as described above, and the resulting yeast transformants were inoculated into liquid SD-medium containing glucose, and grown at 26°C for one day. This and all subsequent media used with these transformants had histidine and leucine omitted to select for pFA and pF1R. The yeast culture was then sub-cultured into SD-medium containing galactose at a starting OD~600~ = 0.075, grown for one day at 26°C, and sub-cultured again in galactose-SD-medium at OD~600~ = 0.075 and grown at 26°C overnight. This final overnight culture was assayed as previously described [@pone.0095799-Kushner1] for FHV replication-dependent expression of *Renilla* luciferase activity.

Data Processing {#s3c}
---------------

The *Renilla* luciferase activity of each deletion strain in relative light units (rlu) was transformed by taking the root to stabilize the variability. The measurement of each yeast strain was normalized to the median measurement of the plate containing that strain. The OD~600~ numbers of all strains were measured to monitor the growth of yeasts, and were normalized to the plate median as well. 5% of the total strains that grew too fast and 5% that grew too slow were removed from the final analysis.

Validation Testing of Yeast Strains {#s3d}
-----------------------------------

For validation testing, selected candidate yeast strains were grown in 96-deep-well plates and transformed as described above with pF1. Four colonies of each transformed strain were picked to check for FHV replication. The yeast were again grown in glucose-SD-medium for one day, then sub-cultured twice in galactose-SD-medium as described above for primary screening. Total yeast RNA was isolated [@pone.0095799-Dye2]. Accumulation of FHV RNAs and 18S rRNA as a loading control were assayed by Northern blot analysis [@pone.0095799-Kushner1]. The RNA signals were quantitated using the Quantity1 (Bio-Rad) software package. Statistical analysis of RNA levels was performed as previously described [@pone.0095799-Gancarz1]. FHV RNA1 and RNA3 levels were normalized to the 18S rRNA level in the same sample.

Using the R statistical package (version R-2.11.1) (<http://www.r-project.org/>), one sided T-tests were performed to identify mutant yeast strains with significantly altered FHV replication relative to wild type yeast. Q-values were calculated based on t-scores to control the false discovery rate under 5% [@pone.0095799-Storey1].

Supporting Information {#s4}
======================

###### 

Whole screen data for FHV replication in yeast knockout library (YKO).

(XLSX)

###### 

Click here for additional data file.
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